製品の概要

  • 製品名Anti-68kDa Neurofilament antibody [EP675Y]
    68kDa Neurofilament 一次抗体 製品一覧
  • 製品の詳細
    Rabbit monoclonal [EP675Y] to 68kDa Neurofilament
  • アプリケーション適用あり: WB, IP, Flow Cytmore details
    適用なし: ICC
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    A synthetic peptide corresponding to residues near the C-term of human NF-L was used as immunogen

  • ポジティブ・コントロール
    • SH-SY5Y cytoplasmic cell lysate
  • 特記事項

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab52989 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/50000. Detects a band of approximately 68 kDa (predicted molecular weight: 61 kDa).
IP 1/50.
Flow Cyt 1/70.

ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.

  • 追加情報Is unsuitable for ICC.
  • ターゲット情報

    • 機能Neurofilaments usually contain three intermediate filament proteins: L, M, and H which are involved in the maintenance of neuronal caliber.
    • 関連疾患Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734]. CMT1F is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT1 group are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1F is characterized by onset in infancy or childhood (range 1 to 13 years).
      Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684]. CMT2E is an autosomal dominant form of Charcot-Marie-Tooth disease type 2. Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.
    • 配列類似性Belongs to the intermediate filament family.
    • ドメインThe extra mass and high charge density that distinguish the neurofilament proteins from all other intermediate filament proteins are due to the tailpiece extensions. This region may form a charged scaffolding structure suitable for interaction with other neuronal components or ions.
    • 翻訳後修飾O-glycosylated.
      Phosphorylated in the Head and Rod regions by the PKC kinase PKN1, leading to inhibit polymerization.
    • Information by UniProt
    • 参照データベース
    • 別名
      • 68 kDa neurofilament protein antibody
      • 68kDa neurofilament protein antibody
      • CMT1F antibody
      • CMT2E antibody
      • FLJ53642 antibody
      • Light molecular weight neurofilament protein antibody
      • NEFL antibody
      • Neurofilament light antibody
      • Neurofilament light polypeptide 68kDa antibody
      • Neurofilament light polypeptide antibody
      • Neurofilament protein, light chain antibody
      • Neurofilament subunit NF L antibody
      • Neurofilament triplet L protein antibody
      • NF-L antibody
      • NF68 antibody
      • NFL antibody
      • NFL_HUMAN antibody
      see all

    Anti-68kDa Neurofilament antibody [EP675Y] 画像

    • Anti-68kDa Neurofilament antibody [EP675Y] (ab52989) at 1/50000 dilution + SH-SY5Y cell lysate at 10 µg

      Secondary
      goat anti-rabbit HRP labelled at 1/2000 dilution

      Predicted band size : 61 kDa
      Observed band size : 68 kDa (why is the actual band size different from the predicted?)

    Anti-68kDa Neurofilament antibody [EP675Y] (ab52989) 使用論文

    This product has been referenced in:
    • Zhao X  et al. Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci 29:6186-95 (2009). WB ; Mouse . Read more (PubMed: 19439596) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab52989.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"